Rs.300 Million New Research and Development Project in Medchal-Malkajgiri, Telangana
A leading pharmaceutical CDMO is establishing a specialized research and development center in Hyderabad, Telangana. Backed by a Rs. 300 million investment, the facility will focus on bulk drugs, intermediates, and advanced analytical development. With environmental clearances now in place, this strategic expansion aims to bolster the company�s R&D capabilities and support its growing global innovation pipeline.
View project